Would you recommend administering IV amino acids prior to cardiac surgery with cardiopulmonary bypass, given recent trial findings of improved AKI rates but no significant difference in kidney-replacement therapy with IV amino acids?

Would you consider administering IV amino acids before cardiac surgery with cardiopulmonary bypass to reduce the risk of post-operative acute kidney injury in light of recent trial findings?

• Yes, the reduction in post-operative AKI rates justifies its use
• No, the lack of significant impact on the need for dialysis or mortality makes its benefits questionable
• Yes, the improvement in Stage 3 AKI suggests a meaningful effect
• No, I am concerned that the reduction in serum creatinine may not reflect genuine kidney function improvement
• Yes, but I would like to see additional data on other kidney injury markers
• Other